Saltar al contenido
Merck

Expanding the phenotype of GMPPB mutations.

Brain : a journal of neurology (2015-02-15)
Macarena Cabrera-Serrano, Roula Ghaoui, Gianina Ravenscroft, Russell D Johnsen, Mark R Davis, Alastair Corbett, Stephen Reddel, Carolyn M Sue, Christina Liang, Leigh B Waddell, Simranpreet Kaur, Monkol Lek, Kathryn N North, Daniel G MacArthur, Phillipa J Lamont, Nigel F Clarke, Nigel G Laing
RESUMEN

Dystroglycanopathies are a heterogeneous group of diseases with a broad phenotypic spectrum ranging from severe disorders with congenital muscle weakness, eye and brain structural abnormalities and intellectual delay to adult-onset limb-girdle muscular dystrophies without mental retardation. Most frequently the disease onset is congenital or during childhood. The exception is FKRP mutations, in which adult onset is a common presentation. Here we report eight patients from five non-consanguineous families where next generation sequencing identified mutations in the GMPPB gene. Six patients presented as an adult or adolescent-onset limb-girdle muscular dystrophy, one presented with isolated episodes of rhabdomyolysis, and one as a congenital muscular dystrophy. This report expands the phenotypic spectrum of GMPPB mutations to include limb-girdle muscular dystrophies with adult onset with or without intellectual disability, or isolated rhabdomyolysis.